हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Jennifer Shannon, Carmela Salomon, Tobin Chettiath, Halim Abbas, Sharief Taraman
Since the U.S. Centers for Disease Control and Prevention began tracking the prevalence of autism spectrum disorder (ASD) over twenty years ago, rates have tripled, with an estimated one in 44 children now receiving a diagnosis [1]. Early ASD diagnosis and intervention during the critical neurodevelopmental window is recommended to enhance long-term outcomes [2-4]; yet many families experience diagnostic delays and challenges accessing services. Diagnostic barriers include long waits for specialist assessment, lengthy and fragmented evaluation processes, and limited primary care diagnostic capacity. Race, ethnicity, gender, geography, and socioeconomic status contribute to further delays for some populations [5-8]. Even after an ASD diagnosis is received, health services may struggle to fund and deliver targeted and timely interventions to the rapidly growing number of children requiring treatment. Data driven approaches to scale, streamline and enhance the quality of diagnostic and therapeutic ASD care available to families are urgently required. This narrative literature review considers the practice change potential of one such approach: Artificial Intelligence (AI) applied to the field of ASD. After providing a brief overview of AI in healthcare, we review a number of ASD specific AI-based approaches and consider their potential to augment current ASD diagnostic or treatment pathways. Key challenges associated with integrating AIbased technologies into clinical practice are also considered.